SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AXYS Pharmaceuticals Inc.
An SI Board Since January 1998
Posts SubjectMarks Bans Symbol
455 17 0 AXPH
Emcee:  tonyt Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
280 Small article on Axys in the July/August issue of Worth magazine PG-51. RecommeRich S-6/25/1999
279 this should help tomorrow. Pharmacia & Upjohn to Acquire SUGEN, Inc. Strabob zagorin-6/15/1999
278 Collaboration with Novalon: Company just keeps cranking away... sticking to itLLCF-6/15/1999
277 Axys Pharmaceuticals' Advanced Technologies Division and Novalon Pharmaceutbob zagorin-6/15/1999
276 BGEN was up strongly on this psoriasis news: Tuesday May 25, 6:51 pm Eastern Ttnsaf-5/30/1999
275 BZ; Well, tryptase works on out of control mast cells which Axys' people fDavid Bogdanoff-5/26/1999
274 that's what i was thinking david that their platform has some special applibob zagorin-5/26/1999
273 DK; I asked about the psoriasis program at today's annual shareholder'David Bogdanoff-5/26/1999
272 Yeah.... I feel that there are many psoriasis programs that have a better chascaram(o)uche-5/26/1999
271 You know my bent on Autoimmune indications... any opinion on this one??? DAK LLCF-5/26/1999
270 Axys Pharmaceuticals Initiates Phase II Human Clinical Trials of Topical Tryptabob zagorin-5/26/1999
269 Hadn't realized how cheap it had grown. Thanks Bob and Dave, for calling mscaram(o)uche-5/17/1999
268 Rick, Thanks for your helpful comments. >>I don't own [AXPH] any RCMac-5/14/1999
267 < big pharmas' judgment is hardly faultless, but when a bunch of them vLLCF-5/13/1999
266 regarding the Boehringer Mannheim project, it'll be fun to watch for this..scaram(o)uche-5/13/1999
265 Bob: I don't own it any longer. Not certain how long I held those shares.scaram(o)uche-5/13/1999
264 >> One thing I thought was very interesting is $300 million of either alRCMac-5/13/1999
263 does anyone know about the overhang from one of the sequana owners who announcebob zagorin-5/12/1999
262 Don't forget the failure of their lead compound... I have also followed thJohn Dwyer-5/12/1999
261 DAK; I have followed this thread for a couple of years. Generally, comments oDavid Bogdanoff-5/12/1999
260 <seemed like an overproduced and expensive document. > Yea, they usuallLLCF-5/12/1999
259 Here's an article about Hepatitis C, one of AXPH's partnerships (with Bbob zagorin-5/6/1999
258 Impressive indeed. However it seemed like an overproduced and expensive documeKushi Kullar-5/6/1999
257 Received my annual report yesterday. Pretty impressive pipeline including advanbob zagorin-5/6/1999
256 Doesn't this (from release) refer to asthma: "... Axys' clinical bob zagorin-4/30/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):